by admin | Apr 19, 2023 | Article
November 30, 2023 – Lupus Canada is pleased to share that Anifrolumab (Saphnelo) will be included on the Alberta Drug Benefit List effective December 1st, 2023. For details regarding this listing and renewal criteria, please visit the Alberta Drug Benefit...
by admin | Mar 22, 2023 | Article
On March 22, 2023 the Government announced a total investment of up to $1.5 billion over three years in support of the first-ever National Strategy for Drugs for Rare Diseases to help increase access to, and affordability of, promising and effective drugs...
by admin | Nov 25, 2022 | Article
On November 25, 2022, the Government of Canada announced the permanent extension of EI sickness benefits from 15 weeks to 26 weeks beginning on December 18, 2022. The change to EI sickness benefits will provide Canadians with additional time and flexibility to recover...
by admin | Nov 17, 2022 | Video
On November 17, 2022 Lupus Canada was joined by Dr. Roger Levy who discussed empowering women living with lupus by educating them on lupus and pregnancy/fertility; what to know and to think of, questions to ask, things to consider, the stigma around lupus and...
by admin | Oct 20, 2022 | Video
On October 20, 2022 Lupus Canada was joined by Dr. Mark Matsos who presented on the safety and efficacy of vaccines as they relate to lupus patients and any updates on the most recent COVID vaccine. Dr. Mark Matsos, FRCPC Associate Professor of Medicine, Michael G....
